Ms.Varney has also challenged agreements that the Federal Trade Commission and consumer groups say discourage pharmaceutical companies from marketing more generic drugs.

• Varney同样受到了协会的挑战，联合贸易组织和消费者协会表示不应鼓励制药公司销售过多学名药。